Knockdown of p66Shc Alters Lineage-Associated Transcription Factor Expression in Mouse Blastocysts.

Stem Cells Dev

1 Department of Physiology and Pharmacology, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, Canada .

Published: November 2018

The p66Shc adaptor protein regulates apoptosis and senescence during early mammalian development. However, p66Shc expression during mouse preimplantation development is upregulated at the blastocyst stage. Our objective was to determine the biological function of p66Shc during mouse blastocyst development. In this study, we demonstrate that a reduced p66Shc transcript abundance following its short interfering RNA (siRNA)-mediated knockdown alters the spatiotemporal expression of cell lineage-associated transcription factors in the inner cell mass (ICM) of the mouse blastocyst. P66Shc knockdown blastocysts restrict OCT3/4 earlier to the inner cells of the early blastocyst and have ICMs containing significantly higher OCT3/4 levels, more GATA4-positive cells, and fewer NANOG-positive cells. P66Shc knockdown blastocysts also show a significantly reduced ability to form ICM-derived outgrowths when explanted in vitro. The increase in cells expressing primitive endoderm markers may be due to increased ERK1/2 activity, as it is reversed by ERK1/2 inhibition. These results suggest that p66Shc may regulate the relative abundance and timing of lineage-associated transcription factor expression in the blastocyst ICM.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209429PMC
http://dx.doi.org/10.1089/scd.2018.0131DOI Listing

Publication Analysis

Top Keywords

lineage-associated transcription
12
transcription factor
8
factor expression
8
expression mouse
8
mouse blastocyst
8
p66shc knockdown
8
knockdown blastocysts
8
p66shc
7
blastocyst
5
knockdown
4

Similar Publications

T cells develop from hematopoietic progenitors in the thymus and protect against pathogens and cancer. However, the emergence of human T cell-competent blood progenitors and their subsequent specification to the T lineage have been challenging to capture in real time. Here, we leveraged a pluripotent stem cell differentiation system to understand the transcriptional dynamics and cell fate restriction events that underlie this critical developmental process.

View Article and Find Full Text PDF
Article Synopsis
  • Advances in high-resolution mapping have revealed complex structures formed by enhancers and promoters, known as enhancer-promoter hubs or cliques, which play a role in gene regulation.
  • This study identifies enhancer-promoter hubs in breast cancer, lymphoma, and leukemia, highlighting their formation at important oncogenes and transcription factors that could drive cancer development.
  • The research also shows that changes in these hubs are linked to shifts in gene expression related to resistance against targeted cancer therapies, indicating their potential impact on both oncogenesis and treatment outcomes.
View Article and Find Full Text PDF

Canine osteosarcoma (OSA) is a malignancy that has been shown to modulate the host immune system. Macrophage colony-stimulating factor (M-CSF; CSF1) and interleukin-34 (IL-34; IL34) are both ligands of colony stimulating factor 1 receptor (CSF-1R), and may play a role in the pathogenesis of a variety of human cancers, including OSA. This study aimed to, (1) assess M-CSF and IL-34 expression in canine OSA cell lines and tissue samples, and (2) determine any correlations between M-CSF and IL-34 expression and immune cell infiltrates within canine OSA tissues.

View Article and Find Full Text PDF

Unlabelled: Hematopoiesis is a tightly regulated process that gets skewed toward myelopoiesis. This restrains lymphopoiesis, but the role of lymphocytes in this process is not well defined. To unravel the intricacies of neutrophil responses in COVID-19, we performed bulk RNAseq on neutrophils from healthy controls and COVID-19 patients.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers systematically mapped these hubs in breast cancer, lymphoma, and leukemia, discovering that they often cluster around key oncogenes and transcription factors linked to cancer development.
  • * The study also revealed that changes in these enhancer-promoter hubs are associated with transcriptional shifts that contribute to drug resistance in specific blood cancers, indicating their dynamic nature and potential influence on cancer treatment outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!